DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Runge-Morris, M.
Right arrow Articles by Kocarek, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Runge-Morris, M.
Right arrow Articles by Kocarek, T. A.

Vol. 26, Issue 8, 795-801, August 1998

Differential Regulation of Individual Sulfotransferase Isoforms by Phenobarbital in Male Rat Liver

Melissa Runge-Morris, Kelly Rose, Charles N. Falany, and Thomas A. Kocarek

Institute of Chemical Toxicology, Wayne State University (M.R.-M., K.R., T.A.K.), and Department of Pharmacology and Toxicology, University of Alabama at Birmingham (C.N.F.)

Xenobiotics that induce the cytochromes P450 also produce changes in rat hepatic sulfotransferase (SULT) gene expression. In the present study, male Sprague-Dawley rats were treated for 3 consecutive days with doses of phenobarbital (PB) that induce cytochrome P450 2B1/2 expression. The effects of PB treatment on hepatic aryl SULT (SULT1) and hydroxysteroid SULT (SULT2) mRNA and immunoreactive protein levels and on mRNA expression of individual SULT1 and SULT2 enzyme isoforms were characterized. PB suppressed SULT1A1 mRNA levels, increased the expression of the SULT-Dopa/tyrosine isoform, and did not produce significant changes in SULT1C1 and SULT1E2 mRNA expression. In rats injected with the highest test dose of PB (100 mg/kg), hepatic SULT1A1 mRNA levels were decreased to ~42% of control levels and SULT-Dopa/tyrosine mRNA levels were increased to ~417% of vehicle-treated control levels. Like the SULT1 subfamily, individual members of the SULT2 gene subfamily were differentially affected by PB treatment. PB (35, 80, and 100 mg/kg) suppressed SULT20/21 mRNA expression to ~61, ~30, and ~41% of vehicle-treated control levels, respectively. In contrast, SULT60 mRNA levels were increased to ~162% of control levels and SULT40/41 mRNA levels were increased to ~416% of vehicle-treated control levels in rats treated with 100 mg/kg PB. These studies support a complex role for PB-mediated effects on the SULT multigene family in rat liver. Because individual SULT1 and SULT2 enzyme isoforms are known to metabolize a variety of potentially toxic substrates, varied responses to PB among members of the SULT multigene family might have important implications for xenobiotic hepatotoxicity.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Alnouti and C. D. Klaassen
Regulation of Sulfotransferase Enzymes by Prototypical Microsomal Enzyme Inducers in Mice
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 612 - 621.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Maiti and G. Chen
Tamoxifen Induction of Aryl Sulfotransferase and Hydroxysteroid Sulfotransferase in Male and Female Rat Liver and Intestine
Drug Metab. Dispos., May 1, 2003; 31(5): 637 - 644.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Z. Duanmu, T. A. Kocarek, and M. Runge-Morris
Transcriptional Regulation of Rat Hepatic Aryl Sulfotransferase (SULT1A1) Gene Expression by Glucocorticoids
Drug Metab. Dispos., August 1, 2001; 29(8): 1130 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. W. H. Coughtrie and L. E. Johnston
Interactions between Dietary Chemicals and Human Sulfotransferases{---}Molecular Mechanisms and Clinical Significance
Drug Metab. Dispos., April 1, 2001; 29(4): 522 - 528.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Runge-Morris, W. Wu, and T. A. Kocarek
Regulation of Rat Hepatic Hydroxysteroid Sulfotransferase (SULT2-40/41) Gene Expression by Glucocorticoids: Evidence for a Dual Mechanism of Transcriptional Control
Mol. Pharmacol., December 1, 1999; 56(6): 1198 - 1206.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.